Insulet | PODD - مصاريف البيع والإدارة





مصاريف البيع والإدارة تغيير تاريخ
Abbott USD 4.27B 669M 2026-09
Align Technology USD 410.55M 52.12M 2026-09
AtriCure USD 82.88M 319K 2026-09
Baxter International USD 730M 5M 2026-09
Becton, Dickinson and Co. USD 1.26B 1000K 2026-09
Boston Scientific USD 1.68B 120M 2026-09
Cardinal Health USD 1.6B 30M 2026-09
Cooper Companies USD 401.3M 274.9M 2026-06
Dexcom USD 358.7M 9M 2026-06
Edwards Lifesciences USD 560.9M 300K 2026-09
Eli Lilly USD 3.12B 305M 2026-09
Globus Medical USD 288.47M 1.65M 2026-09
ICU Medical USD 154.41M 2.48M 2026-09
Inogen USD 43.77M 510K 2024-06
Insulet USD 350.7M 5.9M 2026-09
Integra LifeSciences USD 161.02M 5.2M 2026-09
J&J USD 6.25B 168M 2026-09
Medtronic 3.2B 141M 2026-06
Merit Medical Systems USD 129.23M 18.76M 2026-06
Roche Holding CHF 6.37B 908M 2026-06
Solventum Corp USD 813M 114M 2026-09
Stryker USD 2.12B 32M 2026-06
Tandem Diabetes Care USD 113.94M 2.3M 2026-09
Teleflex USD 220.72M 7.21M 2026-09
West Pharmaceutical Services USD 112.9M 4.7M 2026-09
Zimmer Biomet Holdings USD 855M 56.6M 2026-09